Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment
Background: Immunoglobulin (Ig)G replacement with intravenous or subcutaneous immunoglobulins is a lifelong substitutive therapy in patients with primary antibody deficiencies (PADs). Hemolysis after immunoglobulin therapy was described in patients receiving high immunoglobulin dosages. The issue of hemolysis after immunoglobulin administration at replacement doses has been considered of little clinical significance. Study Design and Methods: This was a single-center observational study over a...[Show more]
|Collections||ANU Research Publications|
|01_Quinti_Hemolysis_in_patients_with_2015.pdf||525.01 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.